What is the best approach to test for hyperandrogenism (high androgen levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Approach to Test for Hyperandrogenism

Total testosterone (TT) and free testosterone (FT) should be used as first-line laboratory tests to assess biochemical hyperandrogenism, with TT measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and FT either measured by equilibrium dialysis or calculated using Free Androgen Index (FAI). 1

Initial Clinical Assessment

  • Document timing of symptom onset
  • Assess severity of symptoms
  • Look for clustering of symptoms:
    • Hirsutism
    • Acne
    • Menstrual irregularities
    • Androgenic alopecia
    • Body odor changes
    • Virilization (clitoromegaly, deepening voice)
    • Truncal obesity 1, 2

First-Line Laboratory Testing

  1. Total Testosterone (TT)

    • Preferably measured by LC-MS/MS (highest accuracy)
    • Avoid direct immunoassays due to lower accuracy
    • Morning collection preferred
  2. Free Testosterone (FT)

    • Gold standard: Equilibrium dialysis or ammonium sulfate precipitation
    • Alternative: Calculate using Free Androgen Index (FAI)
    • FAI = Total testosterone (nmol/L) × 100 / SHBG (nmol/L)

These tests have the highest diagnostic accuracy with:

  • TT: Sensitivity 0.74, Specificity 0.86, AUC 0.87
  • cFT: Sensitivity 0.89, Specificity 0.83, AUC 0.85
  • FAI: Sensitivity 0.78, Specificity 0.85, AUC 0.87 1

Second-Line Laboratory Testing

If TT or FT are not elevated but clinical suspicion remains high, consider:

  1. Androstenedione (A4)

    • Sensitivity 0.75, Specificity 0.71, AUC 0.80
  2. Dehydroepiandrosterone sulfate (DHEAS)

    • Sensitivity 0.75, Specificity 0.67, AUC 0.77
    • Particularly useful for adrenal hyperandrogenism 1, 3

Additional Testing Based on Clinical Presentation

For suspected PCOS:

  • LH:FSH ratio (>2 suggests PCOS)
  • Pelvic ultrasound (to assess for polycystic ovaries) 2, 4

For suspected non-classical congenital adrenal hyperplasia (NCCAH):

  • 17-hydroxyprogesterone (17-OHP) - basal or ACTH-stimulated
  • Two-day dexamethasone suppression test 3, 4

For suspected Cushing's syndrome:

  • 1mg overnight dexamethasone suppression test
  • 24-hour urinary free cortisol 1, 3

For suspected androgen-secreting tumors:

  • Comprehensive androgen panel including:
    • 17β-estradiol
    • 17-OH progesterone
    • Androstenedione
    • 17-OH pregnenolone
    • 11-deoxycorticosterone
    • Progesterone 1

Important Considerations

  • Routine endocrinologic testing is not indicated for most patients with acne alone 1
  • Testing should be performed when clinical signs/symptoms of hyperandrogenism are present (hirsutism, oligomenorrhea, androgenic alopecia, infertility, virilization) 1
  • Severe or rapid-onset hyperandrogenism with virilization should prompt investigation for androgen-secreting tumors 3, 5
  • LC-MS/MS is strongly preferred over immunoassay methods for all androgen measurements due to superior accuracy 1

Common Pitfalls to Avoid

  • Relying solely on direct immunoassay methods, which have lower accuracy
  • Testing without considering clinical context
  • Failing to recognize that isolated acne rarely warrants hormonal testing
  • Not considering potential causes beyond PCOS (adrenal disorders, tumors)
  • Overlooking the need for specialized testing in cases of virilization

By following this systematic approach to testing for hyperandrogenism, clinicians can accurately diagnose the underlying cause and implement appropriate treatment strategies to improve patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperandrogenism in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012

Research

[Hyperandrogenism, adrenal dysfunction, and hirsutism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.